Nuvation Bio Inc.NUVBNYSE
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
635.30%
↓ 24% below average
Average (6y)
840.97%
Historical baseline
Range
High:5101.52%
Low:-18.82%
Volatility
608.9%
High variability
| Period | Value |
|---|---|
| 2024 | 635.30% |
| 2023 | -18.82% |
| 2022 | 27.20% |
| 2021 | 111.75% |
| 2020 | 29.86% |
| 2019 | 5101.52% |
| 2018 | 0.00% |